Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone

Gynecol Oncol. 2006 Oct;103(1):94-9. doi: 10.1016/j.ygyno.2006.01.048. Epub 2006 Mar 9.

Abstract

Objective: To investigate the temporal patterns of anorexia, diarrhea, weight loss, and leukopenia in chemoradiation therapy (CRT) for cervical cancer compared with radiation therapy (RT) alone.

Methods: Acute toxicities in 43 patients receiving RT alone and 40 patients receiving CRT were retrospectively analyzed. Patients were treated with a combination of external beam irradiation and high-dose rate intracavitary irradiation. Cisplatin was given once a week for 5 weeks concurrently with the external beam irradiation. CRT was divided into low-dose CRT group (cisplatin, 20-30 mg/m(2), n = 16) and high-dose CRT group (cisplatin, 35-40 mg/m(2), n = 24). Toxicities were evaluated before, every week up to 7 weeks during the cycle, and 12 weeks after initial irradiation, according to the National Cancer Institute Common Toxicity Criteria version 2.

Results: In the high-dose CRT group, anorexia during the first 5 weeks, leukopenia after 5 weeks, and weight loss after 3 weeks were significantly higher than those in the RT alone group. In the low-dose CRT group, anorexia between 1 and 2 weeks, leukopenia after 5 weeks, and weight loss between 3 and 4 weeks were significantly higher than those in the RT alone group. Diarrhea between 1 and 2 weeks in the high-dose CRT group (P = 0.037, P = 0.025) and between 2 and 3 weeks in the low-dose CRT group (P = 0.015, P = 0.036) was significantly lower compared with RT alone.

Conclusion: These data can help us understand when patients are likely to develop maximal toxicities and to manage them with optimal timing.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Aged
  • Anorexia / chemically induced
  • Anorexia / etiology*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Brachytherapy / adverse effects*
  • Cisplatin / adverse effects*
  • Cisplatin / therapeutic use
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Combined Modality Therapy / adverse effects
  • Diarrhea / chemically induced
  • Diarrhea / etiology*
  • Dose-Response Relationship, Drug
  • Dose-Response Relationship, Radiation
  • Drug Administration Schedule
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Leukopenia / etiology*
  • Middle Aged
  • Patient Compliance
  • Retrospective Studies
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / radiotherapy
  • Uterine Cervical Neoplasms / therapy*
  • Weight Loss / drug effects
  • Weight Loss / radiation effects

Substances

  • Antineoplastic Agents
  • Cisplatin